Court overturns $482M patent decision against J&J

April 4, 2013

(AP)—A federal appeals court says that a Johnson & Johnson heart stent does not infringe a patent held by a doctor and inventor, overturning a $482 million decision against the company.

The three-judge panel said a lower court misinterpreted the company's patent and should not have ruled in favor of Bruce Saffran, a doctor from Princeton, N.J.

Heart stents are mesh-wire tubes that prop open arteries affected by coronary artery disease. The dispute centered over drug-eluting stents, which release a drug to help keep arteries from clogging.

Saffran sued J&J in 2007 saying its Cypher stents infringed on his 1997 patent covering technology to deliver medication inside the body. A Texas jury ruled in Saffran's favor in 2011, concluding J&J had willfully infringed on his .

shares

Related Stories

Recommended for you

Sustaining biomedical research: Med school deans speak out

May 27, 2015

Cuts in federal support and unreliable funding streams are creating a hostile work environment for scientists, jeopardizing the future of research efforts and ultimately clinical medicine, according to leaders of the nation's ...

Why are magazines in practice waiting rooms mainly old?

December 11, 2014

Ever wondered why general practice waiting rooms contain mainly old magazines? Could it be that practice staff put out only old magazines or do they put out reasonably recent ones and these disappear?

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.